SCHEDULE 13G/A

Bicara Therapeutics Inc

Common Stock, par value $0.0001 per share · CUSIP: 055477103

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Invus Public Equities, L.P.

  Shares: 4,861,944.00 · Class: 8.9%

• Invus Public Equities Advisors, LLC

  Shares: 4,861,944.00 · Class: 8.9%

• Invus Global Management, LLC

  Shares: 4,861,944.00 · Class: 8.9%

• Siren, L.L.C.

  Shares: 4,861,944.00 · Class: 8.9%

• Avicenna Life Sci Master Fund LP

  Shares: 355,025.00 · Class: 0.7%

• Avicenna Life Sci Master GP LLC

  Shares: 355,025.00 · Class: 0.7%

• Ulys, L.L.C.

  Shares: 355,025.00 · Class: 0.7%

• Raymond Debbane

  Shares: 5,216,969.00 · Class: 9.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.